BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 36346099)

  • 21. Primary tumor sidedness is an independent prognostic marker for survival in metastatic colorectal cancer: Results from a large retrospective cohort with mutational analysis.
    Kamran SC; Clark JW; Zheng H; Borger DR; Blaszkowsky LS; Allen JN; Kwak EL; Wo JY; Parikh AR; Nipp RD; Murphy JE; Goyal L; Zhu AX; Iafrate AJ; Corcoran RB; Ryan DP; Hong TS
    Cancer Med; 2018 Jul; 7(7):2934-2942. PubMed ID: 29771009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic Survival Associated With Left-Sided vs Right-Sided Colon Cancer: A Systematic Review and Meta-analysis.
    Petrelli F; Tomasello G; Borgonovo K; Ghidini M; Turati L; Dallera P; Passalacqua R; Sgroi G; Barni S
    JAMA Oncol; 2017 Feb; 3(2):211-219. PubMed ID: 27787550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prognostic role of p53 mutations in metastatic colorectal cancer: A systematic review and meta-analysis.
    Ottaiano A; Santorsola M; Capuozzo M; Perri F; Circelli L; Cascella M; Ianniello M; Sabbatino F; Granata V; Izzo F; Iervolino D; Casillo M; Petrillo N; Gualillo O; Nasti G; Savarese G
    Crit Rev Oncol Hematol; 2023 Jun; 186():104018. PubMed ID: 37150312
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment sequencing of metastatic colorectal cancer based on primary tumor location.
    Temraz S; Mukherji D; Nassar F; Moukalled N; Shamseddine A
    Semin Oncol; 2021 Apr; 48(2):119-129. PubMed ID: 34120762
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lymphocyte-to-C-Reactive Protein Ratio Is the Most Sensitive Inflammation-Based Prognostic Score in Patients With Unresectable Metastatic Colorectal Cancer.
    Nakamura Y; Shida D; Boku N; Yoshida T; Tanabe T; Takamizawa Y; Takashima A; Kanemitsu Y
    Dis Colon Rectum; 2021 Nov; 64(11):1331-1341. PubMed ID: 34623347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oncologic Effects of Primary Tumor-Sidedness on Patients with Stages 1-3 Colon Cancer: A Meta-Analysis.
    Ha GW; Kim JH; Lee MR
    Ann Surg Oncol; 2019 May; 26(5):1366-1375. PubMed ID: 30805809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic impact of colorectal cancer patients with bone metastases: a single-center experience.
    Li T; Jing H; Zhang Y; Cao Z; Zhao L; Zhang X; Sun T; Zhang M
    Updates Surg; 2023 Dec; 75(8):2245-2256. PubMed ID: 37976001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Right sided colorectal cancer increases with age and screening should be tailored to reflect this: a national cancer database study.
    Reif de Paula T; Simon HL; Profeta da Luz MM; Keller DS
    Tech Coloproctol; 2021 Jan; 25(1):81-89. PubMed ID: 32852630
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic impact of primary tumor location in Stage III colorectal cancer-right-sided colon versus left-sided colon versus rectum: a nationwide multicenter retrospective study.
    Shida D; Inoue M; Tanabe T; Moritani K; Tsukamoto S; Yamauchi S; Sugihara K; Kanemitsu Y
    J Gastroenterol; 2020 Oct; 55(10):958-968. PubMed ID: 32651860
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of Tumor Location and Variables Associated With Overall Survival in Patients With Colorectal Cancer: A Mayo Clinic Colon and Rectal Cancer Registry Study.
    Wang CB; Shahjehan F; Merchea A; Li Z; Bekaii-Saab TS; Grothey A; Colibaseanu DT; Kasi PM
    Front Oncol; 2019; 9():76. PubMed ID: 30838175
    [No Abstract]   [Full Text] [Related]  

  • 31. Time-varying prognostic effects of primary tumor sidedness and grade after curative liver resection for colorectal liver metastases.
    Syn NL; Chua DW; Raphael Chen L; Tan YC; Goh BKP; Chung Cheow P; Jeyaraj PR; Koh Y; Chung A; Yee Lee S; Lucien Ooi L; Tai BC; Yip Chan C; Teo JY
    Surg Oncol; 2021 Sep; 38():101586. PubMed ID: 33933898
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sidedness is not a prognostic factor in an unselected cohort of patients with colon cancer but prognosis for caecal carcinoma is worse - A multivariate analysis of a large single institution database.
    Stelzner S; Mehdorn M; Puffer E; Bleyl D; Kittner T; Rhode P; Gockel I; Mees ST
    Int J Colorectal Dis; 2024 Feb; 39(1):27. PubMed ID: 38349566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulating T cell subsets are associated with clinical outcome of anti-VEGF-based 1st-line treatment of metastatic colorectal cancer patients: a prospective study with focus on primary tumor sidedness.
    Bencsikova B; Budinska E; Selingerova I; Pilatova K; Fedorova L; Greplova K; Nenutil R; Valik D; Obermannova R; Sheard MA; Zdrazilova-Dubska L
    BMC Cancer; 2019 Jul; 19(1):687. PubMed ID: 31307428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic relevance of sidedness in older patients with colon cancer: A review and pooled analysis of 227,218 patients.
    Petrelli F; Dottorini L; Luciani A
    J Geriatr Oncol; 2024 Jan; 15(1):101624. PubMed ID: 37696686
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic and clinicopathological significance of circulating tumor cells detected by RT-PCR in non-metastatic colorectal cancer: a meta-analysis and systematic review.
    Yang C; Zou K; Zheng L; Xiong B
    BMC Cancer; 2017 Nov; 17(1):725. PubMed ID: 29115932
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exploring the effect of primary tumor sidedness on therapeutic efficacy across treatment lines in patients with metastatic colorectal cancer: analysis of FIRE-3 (AIOKRK0306).
    Modest DP; Stintzing S; von Weikersthal LF; Decker T; Kiani A; Vehling-Kaiser U; Al-Batran SE; Heintges T; Kahl C; Seipelt G; Kullmann F; Scheithauer W; Moehler M; Holch JW; von Einem JC; Held S; Heinemann V
    Oncotarget; 2017 Dec; 8(62):105749-105760. PubMed ID: 29285289
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Time trends in treatment patterns and survival of older patients with synchronous metastatic colorectal cancer in the Netherlands: A population-based study.
    Baltussen JC; de Glas NA; Liefers GJ; Slingerland M; Speetjens FM; van den Bos F; Cloos-van Balen M; Verschoor AJ; Jochems A; Spierings LEAMM; Holterhues C; van Gerven LA; Mooijaart SP; Portielje JEA; Derks MGM
    Int J Cancer; 2023 May; 152(10):2043-2051. PubMed ID: 36620951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of sidedness on survival among patients with early-stage colon cancer: a SEER-based propensity score matching analysis.
    Huang ZS; Wu JW; Li Y; Lin YH; Li XY
    World J Surg Oncol; 2021 Apr; 19(1):127. PubMed ID: 33874958
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic effect of sidedness in early stage versus advanced colon cancer.
    Kennecke HF; Yin Y; Davies JM; Speers CH; Cheung WY; Lee-Ying R
    Health Sci Rep; 2018 Aug; 1(8):e54. PubMed ID: 30623090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of Primary Tumor Location on Second- or Later-Line Treatment With Anti-Epidermal Growth Factor Receptor Antibodies in Patients With Metastatic Colorectal Cancer: A Retrospective Multi-Center Study.
    Archwamety A; Teeyapun N; Siripoon T; Poungvarin N; Tanasanvimon S; Sirachainan E; Akewanlop C; Korphaisarn K
    Front Oncol; 2022; 12():813009. PubMed ID: 35242708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.